Medicare to cover new Alzheimer’s drugs, Eli Lilly says

(By Jakob Emerson for Becker’s Hospital Review)

Eli Lilly is expecting CMS to reverse course on its Medicare coverage policies around new Alzheimer’s drugs as more evidence shows they are capable of reducing amyloid plaques in the brain, Reuters exclusively reported April 21. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org